ProMed VisioPlus Tablet
Natural health product licensed in Canada
- Licence holder
- ProMed Pharmaceutical Inc.
- NPN or DIN-HM
- 80023431
- Status
- Inactive licence
- Licence date
- 21 January 2011
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Zinc: up to 40 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Manganèse: up to 5 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Zinc: up to 40 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (25 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Information
Vitamine B12: the published amount (20 mg) is more than a thousand times the maximum supplement dose: this is very likely a unit error in the source. No dose comparison is made for this nutrient.
contrôle de vraisemblance. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Phosphore Source : Phosphate de calcium, dibasique | 77 mg | 154,000 µg |
| Zinc Source : Produit de chélation de zinc et de protéine végétale hydrolysée (PVH) | 20 mg | 40,000 µg |
| Acide pantothénique Source : D-Pantothénate de calcium | 6 mg | 12,000 µg |
| (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol Source : Lutéine(USP) | 5 mg | Not calculated |
| Vitamine B12 Source : Vitamine B12 | 20 mg | 40,000 µg |
| Tin Source : Chlorure stanneux | 0.005 mg | Not calculated |
| Manganèse Source : Sulfate de manganèse (II) | 2.5 mg | 5,000 µg |
| Potassium Source : Chlorure de potassium | 40 mg | 80,000 µg |
| Sélénium Source : Produit de chélation de sélénium et de protéine végétale hydrolysée (PVH) | 12.5 µg | 25 µg |
| Myo-Inositol Source : Inositol | 5 mg | Not calculated |
| Iode Source : Iodure de potassium | 75 µg | 150 µg |
Non-medicinal ingredients
Cellulose, microcristalline, Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Comprimé ; maximum: 2 Comprimé | minimum: 1 day ; maximum: 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to maintain eyesight, skin, membranes and immune function. Helps in the development and maintenance of night vision. Helps to maintain immune function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80023431
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.